Business
- Influenza Drugs and Vaccines Market with Industry Share, Growth, Trends Analysis by (2024-2034)
13 Oct, 2024 - Pfizer Fizzes Out: From Pandemic Pandemonium To Stunted Growth
13 Oct, 2024 - Cancer Vaccines Market Forecasts from 2024 to 2029: Lung and Breast Cancer Remain Key Targets, FDA Approvals for HPV and HBV Vaccines Boost Expansion
11 Oct, 2024 - GSK, Pfizer Face Declining Respiratory Syncytial Virus Vaccine Sales Due To Narrow Age Recommendations
10 Oct, 2024 - China’s CanSino receives over $17 M from Bill & Melinda Gates Foundation to accelerate polio vaccine development
10 Oct, 2024 - Gritstone Files for Bankruptcy in Effort to Save Clinical Research
10 Oct, 2024 - GSK Settles Zantac Lawsuits for $2.2B, Analysts Now Shift Focus to Vaccines
10 Oct, 2024 - Valneva Hosts Investor Day in New York City
10 Oct, 2024 - AIM Vaccine Co., Ltd.’s (HKG:6660) market cap dropped HK$8.1b last week; Private companies bore the brunt
09 Oct, 2024 - Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine
09 Oct, 2024 - Sanofi launches high-dose flu vaccine in the UK
09 Oct, 2024 - Chinese firm seals deal to construct cholera vaccine plant in Zambia
09 Oct, 2024 - BioVaxys Bolsters Vaccine Development with Expert Advisor
08 Oct, 2024 - GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
08 Oct, 2024 - Pfizer Wins London Court Battle, GSK’s Respiratory Syncytial Virus Vaccine Patents Invalidated
07 Oct, 2024 - Low RSV and COVID vaccine usage is in line with investor expectations, but concerning
07 Oct, 2024 - mRNA licensing agreements double with million-dollar deals
07 Oct, 2024 - Europe’s Pneumococcal Vaccine Market Size Set to Achieve 2.9 Billion By 2032, Growing at 5.8% CAGR As Revea…
07 Oct, 2024 - Zacks SCR sees massive upside in vaccine maker Soligenix amid Marburg virus outbreak
07 Oct, 2024
0 Comments